Probiobitcs effect in pediatric migraine
Phase 2
Recruiting
- Conditions
- Migraine.Migraine
- Registration Number
- IRCT20160523028008N22
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Children aged 5 to 15 years
A definitive diagnosis of migraine disease by a neurologist
Family consent to attend the project
Suitable for the onset of migraine prophylaxis: (leading to school absenteeism or dysfunction, PEDMIDAS of more than 20)
Exclusion Criteria
Other types of headaches, including chronic or drug-related headaches
Inflammatory bowel disease
Having neurological disorders
Use of antibiotics for 2 months before the start of the study
Use of probiotic supplements 2 weeks before the start of the study.
Prohibition of propranolol in patients such as asthma and diabetes.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Monthly frequency of headache. Timepoint: Before and two months after treatment. Method of measurement: Asking from patient.;Severity of headache. Timepoint: Before and two months after treatment. Method of measurement: Asking from patient.;Pediatric Migraine Disability score. Timepoint: Before and two months after treatment. Method of measurement: Asking from patient.
- Secondary Outcome Measures
Name Time Method